Ototoxicity In Persons with CF - Part 2 (Audio)

Ototoxicity impacts many people with cystic fibrosis due to the use of aminoglycosides to treat recurring lung infections. In this two-part webinar, three experts discuss this challenging condition: Ahmet Uluer, DO, MPH, Director of the Adult CF Program at Boston Children's Hospital and Brigham and Women’s Hospital; Angela Garinis, PhD, Audiologist at Oregon Health and Science University; Michael Doing, AuD, audiologist at the University of South Florida, and an adult with cystic fibrosis. In Part 2, they discuss ototoxicity screening and prevention, the management of ototoxicity and future treatments and clinical trials in progress. 

If you watch this podcast episode, please let us know what you think at https://www.surveymonkey.com/r/TMRP766​

Made possible with support from Vertex Pharmaceuticals, Chiesi USA, Viatris, Genentech and Gilead Sciences.